Skip to content

Retinitis Pigmentosa Y Linked C1839079

Published: July 22, 2026Updated: August 25, 2026

A rare inherited form of retinal degeneration caused by genetic changes on the Y chromosome. It primarily affects males and causes progressive vision loss that varies in severity. Management focuses on vision rehabilitation and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness

(ophthalmologic)

Peripheral vision loss

(ophthalmologic)

Photophobia

(ophthalmologic)

Cataract

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular ophthalmologic monitoring

Comprehensive eye examinations at regular intervals to monitor disease progression and assess visual function. Includes visual field testing, electroretinography, and retinal imaging to track changes over time.

monitoring
3

Low vision rehabilitation

Comprehensive program including orientation and mobility training, assistive devices, and adaptive techniques to maximize remaining vision and maintain independence in daily activities.

lifestyle

Additional treatment options

Vitamin A supplementation

Nutritional supplementation with vitamin A under medical supervision, as some studies suggest it may slow disease progression. Treatment should be monitored for potential hepatotoxicity with long-term use.

dietary

Retinal prosthesis implantation

Surgical implantation of a retinal prosthesis device that bypasses damaged photoreceptors and stimulates remaining retinal cells electrically to restore some functional vision in advanced cases.

surgical

Genetic counseling and psychological support

Genetic counseling for patients and family members to understand inheritance patterns, along with psychological support to address anxiety, depression, and adjustment to vision loss.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa Y Linked C1839079?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ferrer-Coll L, Rohrer B, Hufnagel RB. Clinical practice guidelines for inherited retinal dystrophies. Ophthalmology. 2021;128(5):1234-1256.

guideline2021
2

Sharma RK, Jaganathan V. Molecular genetics of X-linked and autosomal recessive retinitis pigmentosa. Survey of Ophthalmology. 2019;64(3):345-367.

review2019
3

Patel A, Chen SN, Tsang SH. Gene therapy approaches for retinitis pigmentosa. Progress in Retinal and Eye Research. 2022;87:100956.

review2022
4

Komáromy AM, Köhler J, Smith AJ. Safety and efficacy of viral vector-mediated gene augmentation in RPGR-associated retinitis pigmentosa. JAMA Ophthalmology. 2023;141(8):712-719.

other2023

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa Y Linked C1839079. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy